Abstract
The present invention is based on the unexpected finding that a number of pterosin compounds possess anti-diabetic and anti-obesity activities.Accordingly, in one aspect, this invention provides a pterosin compound for use in treating diabetes or obesity in a subject, wherein the pterosin compound is one of Compounds 1, 4, 5, 7, 17, 52, 63 and 72-74 as follows: 4cou-glu: 4-O-p-coumaroyl-D-glucose 3glu: 3-O-β-D-glucopyranoside 6cou-glu: 6-O-p-couumaroyl-D-glucose The details of one or more embodiments of the invention are set forth in the description below. Other features or advantages of the present invention will be apparent from the following detailed description of several embodiments, and also from the appended claims.